“The Global Pharmaceutical Wholesale & Distribution market is estimated to be worth $1.3bn in 2023” says new Visiongain report

03 October 2018
Pharma

Visiongain has launched a new pharma report: Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018: Branded Drugs, Generic Drugs, Leading Companies

Growth in the global pharmaceutical wholesale and distribution market has remained steady in recent years. Growth is being held back by government price reductions and generic substitution of expensive branded drugs. However, the global demand for prescription medication is increasing. The ageing population in the developed markets is resulting in increasing prevalence of age-related diseases, which require medical treatment. In the emerging markets, the rapidly expanding middle class and increasing spending on healthcare is creating a high demand for medication. The pharmaceutical wholesale and distribution market is poised for strong growth.

The lead analyst of the report commented "Currently, most emerging pharmaceutical wholesale markets are much more fragmented than their developed counterparts. For example, in the US, the top 3 companies account for more than 95% of the country’s total market. China has seen rapid consolidation in recent years; there, the top 2 companies currently account for more than 45% of the market. The Chinese market will see further rapid consolidation during the forecast period.

During the forecast period there will be significant consolidation in the emerging markets. This will lead to a greater number of national wholesalers, able to serve all regions with greater efficiency and lower costs."

Leading companies featured in the report include Alfresa Holdings, AmerisourceBergen, Anda Inc., Cardinal Health, CR Pharmaceutical, CuraScript Special, Fortissa Limited, H.D. Smith, Mawdsley-Brooks & Co. Ltd., McKesson, MEDIPAL HOLDINGS, Morris & Dickson Co. LLC, North Carolina Mutual Wholesale Drug, Prodigy Health, Shanghai Pharmaceutical Holdings., SINOPHARM, Smith Drug Company, SUZUKEN, The PHOENIX Group, Walgreens Boots Alliance

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focussing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

Read

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

Read

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

Read

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever